What is COPD?

Chronic Obstructive Pulmonary Disease (COPD) is a term commonly used for a group of lung problems including but not limited to emphysema, chronic bronchitis and refractory asthma characterized by severe breathing difficulty and coughing. It is commonly concluded that tobacco smoke is the principal cause for the development of COPD. Both active as well as passive smokers are at higher risk of COPD, along with people who have long term exposure to air pollutants. Apart from the main cause, some of the secondary risk factors are family history, preterm birth, and asthma. The chronic obstructive pulmonary disease changes the respiratory system by damaging the walls of the air sacs as they thicken and become inflamed and lose elasticity. Thus with COPD, the flow of oxygenated air is obstructed resulting in deprivation of oxygen and subsequent complications. Current treatment approaches do not reverse the damage associated with the disease or interrupt the progression completely and are directed at relieving symptoms, slowing progression and preventing complications.

Treatment for COPD at Cellebration Life Sciences, Inc. 

At Cellebration, we have mastered the technology for isolating the maximum number of viable stem cells from either the autologous sources of your own body or allogeneic with the matched donor to treat various patients with COPD. We are a licensed, private organization with a highly technologically equipped specialized facility under development designed to isolate and enrich the viable cell stems which will be infused into the patient. Stem cell treatment for COPD involves administration of concentrated cells in the targeted area to form colonies, adapt the properties of resident stem cells and initiate some of the lost functions that have been compromised by the disease or injury. These cells are administered through one of two methods after a considerable analysis of the patient’s unique history and medical professional’s advice.

  • Local Administration:- In this mode, cells are infused directly at the targeted site of injury. Thus in case of COPD, stem cells are infused directly into the lungs through a catheter based delivery system.
  • Intravenous Administration:- In this mode, cells are infused through the veins to expand blood volumes in the system, to ensure that the maximum number of cells  reach the targeted area.

Once infused back in the body, these cells can be repopulated at the damaged parts of the organ. Through their strong paracrine effects, they differentiate into lost or damaged alveolar epithelial cells of the air sacs. Thus with our standardized, broad based and holistic approach, it is now possible to obtain noticeable improvements in patients with COPD for symptoms as well as their functional abilities.